DSFIR KONINKLIJKE DSM N.V.

dsm-firmenich issues €750 million long-term bond

dsm-firmenich issues €750 million long-term bond

Press Release

dsm-firmenich issues €750 million long-term bond

Kaiseraugst (Switzerland), Maastricht (Netherlands), February 19, 2025

dsm-firmenich today announces the successful launch of a €750 million bond with an 11-year maturity due in 2036, at a coupon of 3.375%. The bond will be issued by DSM B.V. and will be guaranteed by DSM-Firmenich AG pursuant to the previously established .

The proceeds of the new bond will be used for general corporate purposes, including the refinancing of existing indebtedness.

The terms are laid down in the €8 billion Debt Issuance Program of dsm-firmenich alongside the Final Terms of this issuance, both of which are available .

The re-offer price for the 11-year bond tranche was 98.875%. Based on this price, the yield is 3.500%. The bonds will shortly be listed on the Luxembourg Stock Exchange.

DSM-Firmenich AG is rated A3 (stable outlook) by Moody’s and A- (stable outlook) by S&P.



For more information, please contact:

dsm-firmenich investor relations enquiries:

Email:

dsm-firmenich media enquiries:

Email:   

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss company with dual headquarters in Kaiseraugst, Switzerland and Maastricht, Netherlands, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.  

Disclaimer  

This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction. This communication is not for release, distribution or publication, whether directly or indirectly and whether in whole or in part, into or in the United States of America or any (other) jurisdiction where any of such activities would constitute a violation of the relevant laws of such jurisdiction.

The offer of bonds referred to in this communication was limited in the EEA and the United Kingdom to qualified investors only. The bonds have not been and will not be registered under the US Securities Act of 1933, as amended (the “US Securities Act”) and will also not be registered with any authority competent with respect to securities in any state or other jurisdiction of the United States of America. The bonds may not be offered or sold in the United States of America without either registration of the securities or an exemption from registration under the US Securities Act being applicable.

The English language version of this press release prevails over other language versions.

Attachment



EN
19/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on KONINKLIJKE DSM N.V.

 PRESS RELEASE

dsm-firmenich publishes 2025 Integrated Annual Report

dsm-firmenich publishes 2025 Integrated Annual Report Press Release dsm-firmenich publishes 2025 Integrated Annual Report Kaiseraugst (Switzerland), Maastricht (Netherlands), February 20, 2026 dsm-firmenich today announces the publication of its Integrated Annual Report (IAR) for 2025, a year during which the company advanced its innovation-led growth agenda, sharpened its strategic profile, and delivered a good performance. The 2025 IAR offers a comprehensive overview of dsm-firmenich’s financial and non-financial progress during the past year. It details the Group’s performance, inclu...

Guy Sips ... (+3)
  • Guy Sips
  • Mathijs Geerts Danau
  • Wim Hoste
 PRESS RELEASE

dsm-firmenich issues €1.5 billion long-term bonds

dsm-firmenich issues €1.5 billion long-term bonds Press Release dsm-firmenich issues €1.5 billion long-term bonds Kaiseraugst (Switzerland), Maastricht (Netherlands), February 17 2026 dsm-firmenich today announces the successful launch of a €1.5 billion dual-tranche bond issuance, consisting of: €750 million 3.00% fixed-rate notes due 2031€750 million 3.75% fixed-rate notes due 2038   The bonds will be issued by DSM B.V. and guaranteed by DSM-Firmenich AG pursuant to the previously established . The proceeds of the new bonds will be used for refinancing of existing bond maturities. ...

Wim Hoste
  • Wim Hoste

DSM-Firmenich Biting the ANH bullet

The long awaited divestment of ANH disappointed on deal value (EV € 2.2bn, including a potential earn-out of up to € 0.5bn), but creates a group with a much more comprehensive activity and earnings profile. We still appreciate dsm-firmenich for its broad portfolio and market leading positions in consumer-oriented businesses in Nutrition, Health and Beauty. We remind that we have already lowered our target price upon the ANH divestment announcement last week so we maintain our current € 82 target...

Hilde Van Boxstael ... (+3)
  • Hilde Van Boxstael
  • Wim Hoste
  • Wim Lewi

ResearchPool Subscriptions

Get the most out of your insights

Get in touch